Compare $BBNX vs $ENOV | Chartloom

Compare

$BBNX vs $ENOV

Beta Bionics Inc · Enovis Corp

BBNX

Beta Bionics Inc

ENOV

Enovis Corp

Compare $BBNX vs $ENOV

Comparing Beta Bionics Inc and Enovis Corp

BBNXBeta Bionics Inc

ENOVEnovis Corp

BBNXBeta Bionics Inc

Market cap

$793M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

5.37x

Rev growth (TTM)

94.1%

YTD performance

-39.7%

52W performance

-20.3%

FCF yield

-7.7%

ENOVEnovis Corp

Market cap

$1.02B

P/E (TTM)

—

Forward P/E (NTM)

4.57x

Forward P/S (NTM)

0.41x

Rev growth (TTM)

4.9%

YTD performance

-33.3%

52W performance

-44.3%

FCF yield

6.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BBNX

ENOV

Detailed metrics comparison

BBNX

Beta Bionics Inc

ENOV

Enovis Corp

Market Cap

BBNX$793M

ENOV$1.02B

Enterprise Value

BBNX$749M

ENOV$2.29B

Price

BBNX$17.63

ENOV$17.69

P/E Ratio

BBNXN/A

ENOVN/A

P/S Ratio

BBNX6.66x

ENOV0.44x

EV/Sales

BBNX6.29x

ENOV1.00x

EV/EBITDA

BBNX0.00x

ENOV5.92x

P/B Ratio

BBNX3.99x

ENOV0.69x

P/FCF Ratio

BBNXN/A

ENOV16.00x

EV/FCF

BBNX-12.19x

ENOV35.98x

PEG Ratio

BBNXN/A

ENOVN/A

Forward P/E (NTM)

BBNXN/A

ENOV4.57x

Forward P/S (NTM)

BBNX5.37x

ENOV0.41x

Revenue (TTM)

BBNX$119M

ENOV$2.30B

Revenue Growth (YoY)

BBNX94.1%

ENOV4.9%

Forward Rev Growth

BBNX34.2%

ENOV4.9%

Gross Margin (TTM)

BBNX58.3%

ENOV61.4%

Operating Margin (TTM)

BBNX0.0%

ENOV0.0%

EBITDA Margin (TTM)

BBNX-67.9%

ENOV16.9%

Net Margin (TTM)

BBNX-61.3%

ENOV-48.0%

FCF Margin (TTM)

BBNX-51.6%

ENOV2.8%

Net Income (TTM)

BBNX$-73M

ENOV$-1.10B

FCF (TTM)

BBNX$-61M

ENOV$64M

EPS (TTM)

BBNX-$1.64

ENOV-$19.13

ROE (TTM)

BBNX-2630.0%

ENOV-6817.0%

ROA (TTM)

BBNX-2325.0%

ENOV-2777.0%

ROIC (TTM)

BBNX-2630.0%

ENOV-3756.0%

Cash

BBNX$44M

ENOV$13M

Debt

BBNX$0

ENOV$1.28B

Net Cash/Debt

BBNX$44M

ENOV$-1.27B

Current Ratio (TTM)

BBNX8.88x

ENOV1.98x

Quick Ratio (TTM)

BBNX7.72x

ENOV0.92x

Debt/Equity (TTM)

BBNX0.00x

ENOV0.87x

Debt/Assets (TTM)

BBNX0.0%

ENOV0.0%

Interest Coverage (TTM)

BBNXN/A

ENOVN/A

Net Debt/EBITDA (TTM)

BBNX0.00x

ENOV0.00x

Beta

BBNX0.92

ENOV1.45

52W Performance

BBNX-20.3%

ENOV-44.3%

YTD Performance

BBNX-39.7%

ENOV-33.3%

% from 52W High

BBNX-46.1%

ENOV-48.4%

% from 52W Low

BBNX100.3%

ENOV5.9%

Asset Turnover (TTM)

BBNX0.38x

ENOV0.58x

FCF Yield (TTM)

BBNX-7.7%

ENOV6.3%

Earnings Yield (TTM)

BBNX-9.2%

ENOV-108.2%

Dividend Yield (TTM)

BBNXN/A

ENOVN/A

Rule of 40

BBNX42.5

ENOV7.7

EV/GP/RG

BBNX0.34

ENOV0.19

Ticker research

View BBNX research View ENOV research

Metric	BBNX Beta Bionics Inc	ENOV Enovis Corp
Market & Valuation
Market Cap	$793M	$1.02B
Enterprise Value	$749M	$2.29B
Price	$17.63	$17.69
P/E Ratio	N/A	N/A
P/S Ratio	6.66x	0.44x
EV/Sales	6.29x	1.00x
EV/EBITDA	0.00x	5.92x
P/B Ratio	3.99x	0.69x
P/FCF Ratio	N/A	16.00x
EV/FCF	-12.19x	35.98x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	4.57x
Forward P/S (NTM)	5.37x	0.41x
Revenue & Growth
Revenue (TTM)	$119M	$2.30B
Revenue Growth (YoY)	94.1%	4.9%
Forward Rev Growth	34.2%	4.9%
Profitability
Gross Margin (TTM)	58.3%	61.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-67.9%	16.9%
Net Margin (TTM)	-61.3%	-48.0%
FCF Margin (TTM)	-51.6%	2.8%
Net Income (TTM)	$-73M	$-1.10B
FCF (TTM)	$-61M	$64M
EPS (TTM)	-$1.64	-$19.13
ROE (TTM)	-2630.0%	-6817.0%
ROA (TTM)	-2325.0%	-2777.0%
ROIC (TTM)	-2630.0%	-3756.0%
Financial Health
Cash	$44M	$13M
Debt	$0	$1.28B
Net Cash/Debt	$44M	$-1.27B
Current Ratio (TTM)	8.88x	1.98x
Quick Ratio (TTM)	7.72x	0.92x
Debt/Equity (TTM)	0.00x	0.87x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	1.45
52W Performance	-20.3%	-44.3%
YTD Performance	-39.7%	-33.3%
% from 52W High	-46.1%	-48.4%
% from 52W Low	100.3%	5.9%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.58x
FCF Yield (TTM)	-7.7%	6.3%
Earnings Yield (TTM)	-9.2%	-108.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.5	7.7
EV/GP/RG	0.34	0.19
Ticker research	View BBNX research	View ENOV research

Valuation

P/S Ratio

ENOV

0.44x

BBNX

6.66x

EV/FCF

BBNX

-12.19x

ENOV

35.98x

Growth & revenue

Revenue Growth TTM

BBNX

94.1%

ENOV

4.9%

Forward Revenue Growth

BBNX

34.2%

ENOV

4.9%

Profitability & performance

Gross Margin

ENOV

61.4%

BBNX

58.3%

ROE

BBNX

-2630.0%

ENOV

-6817.0%

FCF Yield %

ENOV

6.3%

BBNX

-7.7%

52-Week Performance

BBNX

-20.3%

ENOV

-44.3%

Detailed metrics comparison

BBNX

Beta Bionics Inc

ENOV

Enovis Corp

Market Cap

BBNX$793M

ENOV$1.02B

Enterprise Value

BBNX$749M

ENOV$2.29B

Price

BBNX$17.63

ENOV$17.69

P/E Ratio

BBNXN/A

ENOVN/A

P/S Ratio

BBNX6.66x

ENOV0.44x

EV/Sales

BBNX6.29x

ENOV1.00x

EV/EBITDA

BBNX0.00x

ENOV5.92x

P/B Ratio

BBNX3.99x

ENOV0.69x

P/FCF Ratio

BBNXN/A

ENOV16.00x

EV/FCF

BBNX-12.19x

ENOV35.98x

PEG Ratio

BBNXN/A

ENOVN/A

Forward P/E (NTM)

BBNXN/A

ENOV4.57x

Forward P/S (NTM)

BBNX5.37x

ENOV0.41x

Revenue (TTM)

BBNX$119M

ENOV$2.30B

Revenue Growth (YoY)

BBNX94.1%

ENOV4.9%

Forward Rev Growth

BBNX34.2%

ENOV4.9%

Gross Margin (TTM)

BBNX58.3%

ENOV61.4%

Operating Margin (TTM)

BBNX0.0%

ENOV0.0%

EBITDA Margin (TTM)

BBNX-67.9%

ENOV16.9%

Net Margin (TTM)

BBNX-61.3%

ENOV-48.0%

FCF Margin (TTM)

BBNX-51.6%

ENOV2.8%

Net Income (TTM)

BBNX$-73M

ENOV$-1.10B

FCF (TTM)

BBNX$-61M

ENOV$64M

EPS (TTM)

BBNX-$1.64

ENOV-$19.13

ROE (TTM)

BBNX-2630.0%

ENOV-6817.0%

ROA (TTM)

BBNX-2325.0%

ENOV-2777.0%

ROIC (TTM)

BBNX-2630.0%

ENOV-3756.0%

Cash

BBNX$44M

ENOV$13M

Debt

BBNX$0

ENOV$1.28B

Net Cash/Debt

BBNX$44M

ENOV$-1.27B

Current Ratio (TTM)

BBNX8.88x

ENOV1.98x

Quick Ratio (TTM)

BBNX7.72x

ENOV0.92x

Debt/Equity (TTM)

BBNX0.00x

ENOV0.87x

Debt/Assets (TTM)

BBNX0.0%

ENOV0.0%

Interest Coverage (TTM)

BBNXN/A

ENOVN/A

Net Debt/EBITDA (TTM)

BBNX0.00x

ENOV0.00x

Beta

BBNX0.92

ENOV1.45

52W Performance

BBNX-20.3%

ENOV-44.3%

YTD Performance

BBNX-39.7%

ENOV-33.3%

% from 52W High

BBNX-46.1%

ENOV-48.4%

% from 52W Low

BBNX100.3%

ENOV5.9%

Asset Turnover (TTM)

BBNX0.38x

ENOV0.58x

FCF Yield (TTM)

BBNX-7.7%

ENOV6.3%

Earnings Yield (TTM)

BBNX-9.2%

ENOV-108.2%

Dividend Yield (TTM)

BBNXN/A

ENOVN/A

Rule of 40

BBNX42.5

ENOV7.7

EV/GP/RG

BBNX0.34

ENOV0.19

Ticker research

View BBNX research View ENOV research

Metric	BBNX Beta Bionics Inc	ENOV Enovis Corp
Market & Valuation
Market Cap	$793M	$1.02B
Enterprise Value	$749M	$2.29B
Price	$17.63	$17.69
P/E Ratio	N/A	N/A
P/S Ratio	6.66x	0.44x
EV/Sales	6.29x	1.00x
EV/EBITDA	0.00x	5.92x
P/B Ratio	3.99x	0.69x
P/FCF Ratio	N/A	16.00x
EV/FCF	-12.19x	35.98x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	4.57x
Forward P/S (NTM)	5.37x	0.41x
Revenue & Growth
Revenue (TTM)	$119M	$2.30B
Revenue Growth (YoY)	94.1%	4.9%
Forward Rev Growth	34.2%	4.9%
Profitability
Gross Margin (TTM)	58.3%	61.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-67.9%	16.9%
Net Margin (TTM)	-61.3%	-48.0%
FCF Margin (TTM)	-51.6%	2.8%
Net Income (TTM)	$-73M	$-1.10B
FCF (TTM)	$-61M	$64M
EPS (TTM)	-$1.64	-$19.13
ROE (TTM)	-2630.0%	-6817.0%
ROA (TTM)	-2325.0%	-2777.0%
ROIC (TTM)	-2630.0%	-3756.0%
Financial Health
Cash	$44M	$13M
Debt	$0	$1.28B
Net Cash/Debt	$44M	$-1.27B
Current Ratio (TTM)	8.88x	1.98x
Quick Ratio (TTM)	7.72x	0.92x
Debt/Equity (TTM)	0.00x	0.87x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.92	1.45
52W Performance	-20.3%	-44.3%
YTD Performance	-39.7%	-33.3%
% from 52W High	-46.1%	-48.4%
% from 52W Low	100.3%	5.9%
Efficiency & Yields
Asset Turnover (TTM)	0.38x	0.58x
FCF Yield (TTM)	-7.7%	6.3%
Earnings Yield (TTM)	-9.2%	-108.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	42.5	7.7
EV/GP/RG	0.34	0.19
Ticker research	View BBNX research	View ENOV research